世界の髄膜炎菌感染症ワクチン市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Meningococcal Infections Vaccine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12465 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、髄膜炎菌感染症ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。髄膜炎菌感染症ワクチンの種類別市場規模（4価（血清型A、C、W-135、Y）、2価（血清型C・Y）、血清型A、血清型B、血清型X）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・髄膜炎菌感染症ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Creative Biolabs(USA)、SERUM INSTITUTE OF INDIA PVT.LTD.(India) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：4価（血清型A、C、W-135、Y）、2価（血清型C・Y）、血清型A、血清型B、血清型X ・用途別分析2016年-2026年：病院、クリニック ・髄膜炎菌感染症ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・髄膜炎菌感染症ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・髄膜炎菌感染症ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・髄膜炎菌感染症ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・髄膜炎菌感染症ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Meningococcal Infections Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Meningococcal Infections Vaccine size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Meningococcal Infections Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Meningococcal Infections Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Quadrivalent (Serogroups A, C, W-135, and Y)
Bivalent (Serogroups C and Y)
Serogroup A
Serogroup B
Serogroup X

Market segment by Application, can be divided into
Hospital
Clinic

Market segment by players, this report covers
Creative Biolabs(USA)
SERUM INSTITUTE OF INDIA PVT.LTD.(India)

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Meningococcal Infections Vaccine
1.2 Classification of Meningococcal Infections Vaccine by Type
1.2.1 Overview: Global Meningococcal Infections Vaccine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Meningococcal Infections Vaccine Revenue Market Share by Type in 2020
1.2.3 Quadrivalent (Serogroups A, C, W-135, and Y)
1.2.4 Bivalent (Serogroups C and Y)
1.2.5 Serogroup A
1.2.6 Serogroup B
1.2.7 Serogroup X
1.3 Global Meningococcal Infections Vaccine Market by Application
1.3.1 Overview: Global Meningococcal Infections Vaccine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Meningococcal Infections Vaccine Market Size & Forecast
1.5 Global Meningococcal Infections Vaccine Market Size and Forecast by Region
1.5.1 Global Meningococcal Infections Vaccine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Meningococcal Infections Vaccine Market Size by Region, (2016-2021)
1.5.3 North America Meningococcal Infections Vaccine Market Size and Prospect (2016-2026)
1.5.4 Europe Meningococcal Infections Vaccine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Meningococcal Infections Vaccine Market Size and Prospect (2016-2026)
1.5.6 South America Meningococcal Infections Vaccine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Meningococcal Infections Vaccine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Meningococcal Infections Vaccine Market Drivers
1.6.2 Meningococcal Infections Vaccine Market Restraints
1.6.3 Meningococcal Infections Vaccine Trends Analysis
2 Company Profiles
2.1 Creative Biolabs(USA)
2.1.1 Creative Biolabs(USA) Details
2.1.2 Creative Biolabs(USA) Major Business
2.1.3 Creative Biolabs(USA) Meningococcal Infections Vaccine Product and Solutions
2.1.4 Creative Biolabs(USA) Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Creative Biolabs(USA) Recent Developments and Future Plans
2.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India)
2.2.1 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Details
2.2.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Major Business
2.2.3 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Product and Solutions
2.2.4 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Meningococcal Infections Vaccine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Meningococcal Infections Vaccine Players Market Share
3.2.2 Top 10 Meningococcal Infections Vaccine Players Market Share
3.2.3 Market Competition Trend
3.3 Meningococcal Infections Vaccine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Meningococcal Infections Vaccine Revenue and Market Share by Type (2016-2021)
4.2 Global Meningococcal Infections Vaccine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Meningococcal Infections Vaccine Revenue Market Share by Application (2016-2021)
5.2 Meningococcal Infections Vaccine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Meningococcal Infections Vaccine Revenue by Type (2016-2026)
6.2 North America Meningococcal Infections Vaccine Revenue by Application (2016-2026)
6.3 North America Meningococcal Infections Vaccine Market Size by Country
6.3.1 North America Meningococcal Infections Vaccine Revenue by Country (2016-2026)
6.3.2 United States Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
6.3.3 Canada Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
6.3.4 Mexico Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Meningococcal Infections Vaccine Revenue by Type (2016-2026)
7.2 Europe Meningococcal Infections Vaccine Revenue by Application (2016-2026)
7.3 Europe Meningococcal Infections Vaccine Market Size by Country
7.3.1 Europe Meningococcal Infections Vaccine Revenue by Country (2016-2026)
7.3.2 Germany Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
7.3.3 France Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
7.3.5 Russia Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
7.3.6 Italy Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Meningococcal Infections Vaccine Revenue by Type (2016-2026)
8.2 Asia-Pacific Meningococcal Infections Vaccine Revenue by Application (2016-2026)
8.3 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region
8.3.1 Asia-Pacific Meningococcal Infections Vaccine Revenue by Region (2016-2026)
8.3.2 China Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
8.3.3 Japan Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
8.3.4 South Korea Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
8.3.5 India Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
8.3.7 Australia Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Meningococcal Infections Vaccine Revenue by Type (2016-2026)
9.2 South America Meningococcal Infections Vaccine Revenue by Application (2016-2026)
9.3 South America Meningococcal Infections Vaccine Market Size by Country
9.3.1 South America Meningococcal Infections Vaccine Revenue by Country (2016-2026)
9.3.2 Brazil Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
9.3.3 Argentina Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Meningococcal Infections Vaccine Revenue by Type (2016-2026)
10.2 Middle East & Africa Meningococcal Infections Vaccine Revenue by Application (2016-2026)
10.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country
10.3.1 Middle East & Africa Meningococcal Infections Vaccine Revenue by Country (2016-2026)
10.3.2 Turkey Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
10.3.4 UAE Meningococcal Infections Vaccine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Meningococcal Infections Vaccine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Meningococcal Infections Vaccine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Meningococcal Infections Vaccine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Meningococcal Infections Vaccine Revenue (USD Million) by Region (2016-2021)
Table 5. Global Meningococcal Infections Vaccine Revenue Market Share by Region (2021-2026)
Table 6. Creative Biolabs(USA) Corporate Information, Head Office, and Major Competitors
Table 7. Creative Biolabs(USA) Major Business
Table 8. Creative Biolabs(USA) Meningococcal Infections Vaccine Product and Solutions
Table 9. Creative Biolabs(USA) Meningococcal Infections Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Corporate Information, Head Office, and Major Competitors
Table 11. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Major Business
Table 12. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Product and Solutions
Table 13. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Global Meningococcal Infections Vaccine Revenue (USD Million) by Players (2019-2021)
Table 15. Global Meningococcal Infections Vaccine Revenue Share by Players (2019-2021)
Table 16. Breakdown of Meningococcal Infections Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 17. Meningococcal Infections Vaccine Players Head Office, Products and Services Provided
Table 18. Meningococcal Infections Vaccine Mergers & Acquisitions in the Past Five Years
Table 19. Meningococcal Infections Vaccine New Entrants and Expansion Plans
Table 20. Global Meningococcal Infections Vaccine Revenue (USD Million) by Type (2016-2021)
Table 21. Global Meningococcal Infections Vaccine Revenue Share by Type (2016-2021)
Table 22. Global Meningococcal Infections Vaccine Revenue Forecast by Type (2021-2026)
Table 23. Global Meningococcal Infections Vaccine Revenue by Application (2016-2021)
Table 24. Global Meningococcal Infections Vaccine Revenue Forecast by Application (2021-2026)
Table 25. North America Meningococcal Infections Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 26. North America Meningococcal Infections Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 27. North America Meningococcal Infections Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 28. North America Meningococcal Infections Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 29. North America Meningococcal Infections Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 30. North America Meningococcal Infections Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 31. Europe Meningococcal Infections Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 32. Europe Meningococcal Infections Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 33. Europe Meningococcal Infections Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 34. Europe Meningococcal Infections Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 35. Europe Meningococcal Infections Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 36. Europe Meningococcal Infections Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 37. Asia-Pacific Meningococcal Infections Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 38. Asia-Pacific Meningococcal Infections Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 39. Asia-Pacific Meningococcal Infections Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 40. Asia-Pacific Meningococcal Infections Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 41. Asia-Pacific Meningococcal Infections Vaccine Revenue by Region (2016-2021) & (USD Million)
Table 42. Asia-Pacific Meningococcal Infections Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 43. South America Meningococcal Infections Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 44. South America Meningococcal Infections Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 45. South America Meningococcal Infections Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 46. South America Meningococcal Infections Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 47. South America Meningococcal Infections Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 48. South America Meningococcal Infections Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 49. Middle East & Africa Meningococcal Infections Vaccine Revenue by Type (2016-2021) & (USD Million)
Table 50. Middle East & Africa Meningococcal Infections Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 51. Middle East & Africa Meningococcal Infections Vaccine Revenue by Application (2016-2021) & (USD Million)
Table 52. Middle East & Africa Meningococcal Infections Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 53. Middle East & Africa Meningococcal Infections Vaccine Revenue by Country (2016-2021) & (USD Million)
Table 54. Middle East & Africa Meningococcal Infections Vaccine Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Meningococcal Infections Vaccine Picture
Figure 2. Global Meningococcal Infections Vaccine Revenue Market Share by Type in 2020
Figure 3. Quadrivalent (Serogroups A, C, W-135, and Y)
Figure 4. Bivalent (Serogroups C and Y)
Figure 5. Serogroup A
Figure 6. Serogroup B
Figure 7. Serogroup X
Figure 8. Meningococcal Infections Vaccine Revenue Market Share by Application in 2020
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Global Meningococcal Infections Vaccine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Meningococcal Infections Vaccine Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Meningococcal Infections Vaccine Revenue Market Share by Region (2016-2026)
Figure 14. Global Meningococcal Infections Vaccine Revenue Market Share by Region in 2020
Figure 15. North America Meningococcal Infections Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Meningococcal Infections Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Meningococcal Infections Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Meningococcal Infections Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Meningococcal Infections Vaccine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Meningococcal Infections Vaccine Market Drivers
Figure 21. Meningococcal Infections Vaccine Market Restraints
Figure 22. Meningococcal Infections Vaccine Market Trends
Figure 23. Creative Biolabs(USA) Recent Developments and Future Plans
Figure 24. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Developments and Future Plans
Figure 25. Global Meningococcal Infections Vaccine Revenue Share by Players in 2020
Figure 26. Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players Meningococcal Infections Vaccine Revenue Market Share in 2020
Figure 28. Global Top 10 Players Meningococcal Infections Vaccine Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global Meningococcal Infections Vaccine Revenue Share by Type in 2020
Figure 31. Global Meningococcal Infections Vaccine Market Share Forecast by Type (2021-2026)
Figure 32. Global Meningococcal Infections Vaccine Revenue Share by Application in 2020
Figure 33. Global Meningococcal Infections Vaccine Market Share Forecast by Application (2021-2026)
Figure 34. North America Meningococcal Infections Vaccine Sales Market Share by Type (2016-2026)
Figure 35. North America Meningococcal Infections Vaccine Sales Market Share by Application (2016-2026)
Figure 36. North America Meningococcal Infections Vaccine Revenue Market Share by Country (2016-2026)
Figure 37. United States Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe Meningococcal Infections Vaccine Sales Market Share by Type (2016-2026)
Figure 41. Europe Meningococcal Infections Vaccine Sales Market Share by Application (2016-2026)
Figure 42. Europe Meningococcal Infections Vaccine Revenue Market Share by Country (2016-2026)
Figure 43. Germany Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Meningococcal Infections Vaccine Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific Meningococcal Infections Vaccine Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific Meningococcal Infections Vaccine Revenue Market Share by Region (2016-2026)
Figure 51. China Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America Meningococcal Infections Vaccine Sales Market Share by Type (2016-2026)
Figure 58. South America Meningococcal Infections Vaccine Sales Market Share by Application (2016-2026)
Figure 59. South America Meningococcal Infections Vaccine Revenue Market Share by Country (2016-2026)
Figure 60. Brazil Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa Meningococcal Infections Vaccine Revenue Market Share by Country (2016-2026)
Figure 65. Turkey Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE Meningococcal Infections Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source

---